Variation in brain monoaminergic activity is heritable and modulates risk of alcoholism and other addictions, as well as food intake and energy expenditure. Monoamine oxidase A deaminates the monoamine neurotransmitters serotonin, dopamine (DA), and noradrenalin. The monoamine oxidase A (MAOA) gene (Xp11.5) contains a length polymorphism in its promoter region (MAOA-LPR) that putatively affects transcriptional efficiency. Our goals were to test (1) whether MAOA-LPR contributes to interindividual variation in monoamine activity, assessed using levels of cerebrospinal fluid (CSF) monoamine metabolites; and (2) whether MAOA-LPR genotype influences alcoholism and/or body mass index (BMI). Male, unrelated criminal alcoholics (N = 278) and controls (N = 227) were collected from a homogeneous Finnish source population. CSF concentration of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) were available from 208 participants. Single allele, hemizygous genotypes were grouped according to inferred effect of the MAOA alleles on transcriptional activity. MAOA-LPR genotypes had a significant effect on CSF HVA concentration (P = 0.01) but explained only 3% of the total variance. There was a detectable but nonsignificant genotype effect on 5-HIAA and no effects on MHPG. Specifically, the genotype conferring high MAOA activity was associated with lower HVA levels in both alcoholics and controls, a finding that persisted after accounting for the potential confounds of alcoholism, BMI, height, and smoking. MAOA-LPR genotype predicted BMI (P < 0.005), with the high-activity genotype being associated with lower BMI. MAOA-LPR genotypes were not associated with alcoholism or related psychiatric phenotypes in this data set. Our results suggest that MAOA-LPR allelic variation modulates DA turnover in the CNS, but does so in a manner contrary to our prior expectation that alleles conferring high activity would predict higher HVA levels in CSF. Our results are consistent with an emerging literature that suggests greater complexity in how variation in MAOA expression alters monoaminergic function. Finally, our work suggests that MAOA may be involved in the regulation of BMI. Independent samples are necessary to confirm this preliminary finding.
Introduction
The monoamine oxidase A (MAOA) gene codes for a mitochondrial enzyme (EC 1.4.3.4) that metabolizes monoamine neurotransmitters, including noradrenalin (NE), dopamine (DA), and serotonin (5-HT). In animals models, MAO inhibitors have been shown to lower the levels of monoamine metabolites; 1,2 consistently, MAOA knockout mice have higher levels of DA, 5-HT and NE, and manifest increased aggressive behavior. 3 The key role of MAOA in modulating monoamine turnover suggests that its gene (MAOA), located on the X chromosome (Xp11.23), is a logical candidate for investigating interindividual differences in vulnerability to psychiatric disorders, especially in males. Studies in both humans and non-human animal models have supported the involvement of MAOA in the etiology of externalizing behaviors, including impulsivity and aggression and several psychiatric disorders in which these behaviors play a role, including antisocial personality disorder (ASPD), conduct disorder (CD), attention deficit hyperactivity disorder (ADHD), and alcoholism [4] [5] [6] [7] [8] [9] [10] In 1993, Brunner et al. 4, 11 reported a Dutch family in which eight males were affected by a syndrome characterized by borderline mental retardation and impulsive behavior including impulsive aggression, arson, attempted rape, fighting, and exhibitionism The syndrome was due to a stop-codon variant in the eighth exon of MAOA leading to complete and selective deficiency of MAOA activity. This stopcodon variant has not been observed in other study populations; however, subsequent efforts led to the discovery of a common MAOA polymorphism that was shown to affect transcriptional activity [12] [13] [14] and that is generally assumed to result in a deficiency of MAOA in vivo. This locus, termed 'MAOA linked polymorphic region' (MAOA-LPR or MAOA-uVNTR), is a variable number of tandem repeats (VNTR) located in the gene's transcriptional control region, approximately 1.2 kb upstream of the start codon. 12, 14 Alleles at this VNTR differ in the number of copies (2, 3, 3.5, 4, 5, or 6) of a 30-bp repeat motif, with the 3 and 4 repeat alleles being by far the most common. Alleles with 3.5 and 4 repeats appear to be transcribed more efficiently than alleles with 3 copies. 12, 14 However, it still remains unclear whether the 5 repeat allele is associated with high 14 or low 12 MAOA activity. As MAOA is located on the X chromosome, males inherit a single allele, hemizygous genotype, and in most analyses are clustered according to their inferred effect on transcriptional activity. An excess of low activity alleles has been reported in antisocial alcoholics, 5, 7 alcoholics in general, 8 patients with ADHD and CD, 9 and subjects with cluster B personality disorders. 10 Yet several studies have failed to replicate these findings 15 and others have found that genotypes conferring high, rather than low, MAOA activity are associated with ADHD 16 and increased impulsivity, hostility, and aggression. 17 The role of MAOA in the development of antisocial behaviors has been partially clarified by studies evaluating gene -environment interaction. Studies in humans 6, 18, 19 and other primates 20 have demonstrated that MAOA genotypes influence the risk for antisocial behavior contingent on exposure to certain environmental factors. Adverse experiences early in life, such as childhood maltreatment, play a crucial role in the development of antisocial behavior. In a longitudinal sample of males, 6 it was shown that children who suffered maltreatment (defined as maternal rejection, loss of primary caregiver, harsh discipline, physical abuse, or sexual abuse), who also carried a low-expression MAOA genotype were most likely to develop antisocial problems later in life. Although there was an independent effect of maltreatment, no independent effect of MAOA genotype was detected for risk of antisocial behavior. 6 These results were later replicated. 18, 19 In rhesus monkeys, a functional polymorphism orthologous to the human MAOA VNTR was found to influence both elicited and naturally occurring aggression in males. 20 The effect was mediated by whether the monkeys had been raised with their mothers, or in peer only nursery groups, with the highest measures of aggression occurring in mother reared monkeys with the low MAOA activity associated allele. 20 Cerebrospinal fluid (CSF) concentrations of the major metabolites of 5-HT (5-hydroxyindoleacetic acid, 5-HIAA), DA (homovanillic acid, HVA), and NE (3-methoxy-4-hydroxyphenylglycol, MHPG) are indirect measures of monoamine function in the human central nervous system (CNS). Several studies have demonstrated that levels of monoamine metabolites, especially 5-HIAA, are associated with aggressiveness and impulsivity, 21 thus suggesting that these measures might be appropriate intermediate phenotypes for more complex phenotypes such as externalizing disorders.
Low CSF 5-HIAA levels are found in violent offenders 22 and in suicide attempters. 23, 24 Low levels of HVA were reported in individuals with a family history of alcoholism and violence 22 as well as in suicide attempters. However, other studies have failed to find any correlations between HVA and aggressive behaviors. 24 Although findings on NE metabolites are more controversial, low MHPG 21, 25 levels were reported in a sample of violent offenders. 22 Studies in humans 26 and other primates 27, 28 suggest that CSF levels of monoamine metabolites are heritable and that genes influencing 5-HIAA, HVA, and MHPG concentrations partially overlap. 28 Since MAOA is one of the major enzymes responsible for monoamine degradation within the CNS, it is plausible to assert that functional variants within the gene might contribute to interindividual differences in brain monoamine activity that, in turn, might alter the risk of developing antisocial-related disorders. To date, only a few studies [29] [30] [31] have evaluated the influence of MAOA-LPR on CSF monoamine metabolite levels in humans, with controversial results. In a sample of 165 healthy volunteers, males with high activity alleles displayed higher 5-HIAA than males with low activity alleles, whereas no differences were detected among women. 29 Zahlsman et al. 31 in a clinical sample of 98 subjects found that high activity genotypes were associated with high HVA among males. Finally, in a study conducted on 88 healthy volunteers Jonsson et al. 30 found that high activity genotypes were associated with higher HVA and 5-HIAA metabolite levels in women, but with lower CSF HVA levels in men.
The role of MAOA in modulating central monoamine levels suggests that this gene may also be a plausible candidate in the regulation of body weight. Monoamines, jointly with neuropeptides such as NPY, belong to a complex network that regulates food intake and energy expenditure. 32 Thus, neurobiological pathways involved in addiction and other psychiatric diseases may partially overlap with those that modulate BMI. Indeed, most of the drugs that have been used so far in the treatment of obesity, such as amphetamine-like drugs, act on the monoamine systems and are well known to be psychoactive. 32 Moreover, obesity is often comorbid with psychiatric Association between MAOA, dopamine function and BMI F Ducci et al diseases including mood and binge eating disorders, 33 and abnormal levels of CSF monoamine metabolites have been described in patients with eating disorders, and at least some of these changes appear to be trait rather than state dependent. 34 Furthermore, DA is known to modulate the rewarding properties of psychoactive drugs as well as food via the mesolimbic reward system. 35 In this regard, it has been hypothesized that a dysfunction of the DA mesolimbic reward system might underlie vulnerability to a spectrum of disorders characterized by dyscontrol and impulsive behaviors such as drug addiction and eating disorders, which probably include some forms of obesity. 36 The possible involvement of MAOA in obesity is supported by a whole genome linkage study implicating a locus for obesity on the p arm of the X chromosome, 37 as well as a study in which low activity MAOA alleles were associated with obesity in one familial data set. 38 Finally, MAOA inhibitors, at least the irreversible types, typically cause weight gain. 39 The goal of the present study is to test the hypothesis that heritable variation in MAOA-LPR contributes to interindividual differences in (1) CSF levels of monoamine metabolites; (2) the risk of developing alcoholism and other related externalizing phenotypes such as ASPD, borderline personality disorder (BPD), intermittent explosive disorder (IED), and high novelty seeking (NS); and (3) body mass index (BMI).
Methods
The protocol was approved by the institutional review board of the National Institutes of Health, the Office for Protection from Research Risks, the University of Helsinki Department of Psychiatry institutional review board, and the University of Helsinki Central Hospital institutional review board. All subjects provided informed consent before entering the study.
Human subjects
The sample (N = 505) consisted of unrelated male criminal alcoholics and controls collected from the relatively homogeneous Finnish source population. The index cases were 278 criminal alcoholics who, because of the extreme nature of their crimes, were remanded to forensic psychiatric examination at the time of initial incarceration. These subjects spent an average of 1 month on the research ward, were maintained on a low monoamine diet, and were drug and alcohol free.
The control population consisted of 227 psychiatrically interviewed healthy Finnish male volunteers recruited by advertisements in local newspapers and paid for their participation. They were asked to follow a low monoamine diet and not use any alcohol or medicines for a week prior to admission, and were then housed on the same research ward for 3 days and nights. Population controls were also in good general health, as established by physical examination, normal erythrocyte and lymphocyte indexes, liver enzyme and thyroid hormone levels, and serum electrolyte and creatinine concentrations.
Psychiatric assessment
Lifetime psychiatric diagnoses were made using the Structured Clinical Interview (SCID) according to DSM-III-R criteria for all disorders except IED. IED was diagnosed according to DSM-III criteria because DSM-III-R does not allow the IED diagnosis if symptoms occurred only when the subject was under the influence of alcohol. Diagnoses were independently blind-rated from interview data by two research psychiatrists under the supervision of a senior research psychiatrist (GLB). Interrelater reliability was very high between the two psychiatrists blindly rating the interview. Differences were resolved by GLB, who was blind to the biochemical data.
Most participants (86%) with an alcohol use disorders diagnosis (defined as either alcohol abuse or dependence) were alcohol dependents. This sample of criminal alcoholics is enriched for socalled type II alcoholism as demonstrated by high rates of comorbidity with externalizing psychopathologies, including ASPD (59%), BPD (42%), IED (18%), and addictive disorders other than alcoholism (defined as abuse or dependence for cannabis, stimulants, or sedatives) (17%), as well as relatively early age at onset (mean7s.d. = 20.8075.54). Auto-aggressive behaviors were also common, with 53% of alcoholics reporting at least one suicide attempt.
Twenty-one controls were affected by at least one Axis I or II disorder: major depression (n = 3), dysthymia (n = 10), panic disorder (n = 10), social phobia (n = 1), substance use disorder other than alcoholism (n = 20), IED (n = 10), and personality disorders other than BPD or ASPD (n = 5). Subjects with substance use disorder other than alcoholism and/or IED (n = 3) were excluded as controls.
Temperament assessment
Personality traits related to externalizing disorders were measured using the NS scale from the Tridimensional Personality Questionnaire (TPQ).
CSF monoamine metabolites CSF samples from 208 participants, composed of 57 controls and 151 alcoholics, were obtained by lumbar puncture between 0800 and 0900. Concentrations of 5-HIAA, HVA, and MHPG were measured in the first 12 ml of CSF collected, using high-performance liquid chromatography and electrochemical detection. 40 
Smoking behavior
Since smoking inhibits both MAOA and MAOB enzymes, 41 it is likely to influence levels of CSF monoamine metabolites. Therefore, data on smoking behavior (number of cigarettes smoked per day in the last 6 months) were collected in a subset of 402 , which is the cutoff commonly used to define obese subjects.
Genotyping
The MAOA gene promoter VNTR polymorphism was amplified from 25 ng genomic DNA using the primer sequences: Forward 5 0 -CCC AGG CTG CTC CAG AAA CAT G-3 0 and Reverse-5 0 GTT CGG GAC CTG GGC AGT TGT G-3 0 . Owing to the high GC content in the VNTR region, amplification was performed using Invitrogen's PlatinumTaq and PCRX Enhancer System kits, according to the manufacturer's protocol (Invitrogen, Carlsbad, CA, USA), with 5 mM of each primer and 25 mM dNTPs in a total reaction volume of 15 ml. Amplifications were performed on a Perkin-Elmer 9700 thermocycler (Applied Biosystems, Foster City, CA, USA) with one cycle at 961C for 10 min followed by 30 cycles of 941C for 15 s, 601C for 15 s, 721C for 30 s, and a final 3 min extension at 721C. The forward primer was labeled with the fluorescent dye 6-FAM, and amplicons were visualized on an ABI 3100 capillary sequencer. Allele sizes (allele 3, 263 bp; allele 3.5, 278 bp; allele 4, 293 bp; allele 5, 323 bp) were determined using Genotyper 2.5 (Applied Biosystems, Foster City, CA, USA).
As the study sample was composed of males only, genotypes were grouped by relative transcriptional activity into two categories: high function (3.5 or 4 repeats) versus low function (3 or 5 repeats). 12 As the effect of the 5-repeat allele on transcription was inconsistent across studies 12, 14 analyses were repeated excluding the four participants who had the 5-repeat genotype.
Statistical analyses
Mean CSF values were compared between high-and low-activity genotype groups using Student's t-test. We used Analysis of Covariance (ANCOVA) to determine whether the effect of MAOA genotype on CSF monoamine metabolite concentrations was influenced by confounding factors. Parameters entered as independent variables were: (1) MAOA genotype, (2) diagnosis of alcoholism, (3) amount of tobacco used, (4) height, and (5) BMI. Data for all five variables, as well as CSF measures, were available for 166 participants (46 controls and 120 alcoholics) and thus ANCOVA was conducted only on this subset of individuals. Both t-test and ANCOVA excluding alcoholism as a covariate were conducted first for the whole sample, then for controls and alcoholics separately. Mean BMI and NS scores were compared between genotype groups using ANCOVA to adjust for age. w 2 -test was used to compare allele frequencies across discrete variables (psychiatric diagnoses). Mean CSF monoamine metabolites levels were compared between alcoholics and controls using Student's t-test. Correlations between continuous variables were computed using linear regression. All analyses were conducted using JMP software v5.1 (SAS Institute, Cary, NC, USA). Criterion for statistical significance was set at 0.05.
Results
Genotyping was completed on 488 of 505 subjects (97%). Allele frequencies fell within expected ranges, based on multiple published reports for Caucasians. Alleles with 3 or 4 repeats were by far the most common, with frequencies of 0.39 and 0.58, respectively, whereas alleles with 3.5 and 5 repeats were detected on only 3 and 4 chromosomes, respectively.
Effect of MAOA-LPR genotype on CSF monoamine metabolites levels HVA. A significant effect of MAOA genotype on CSF monoamine metabolite levels was detected only for HVA (see Table 1 ). Low-activity genotype was associated with higher HVA levels (P < 0.01) in the total sample, with nonsignificant trends in the same direction in both alcoholics (P = 0.06) and controls (P = 0.10). A post hoc analysis indicated sufficient power (0.80) for detecting a significant effect in the total sample, but also indicated a minimum sample size of 126 subjects. Therefore, our sample may be underpowered to detect a significant effect in alcoholics and controls separately. Within the total sample, MAOA-LPR genotype explains only 3% of total variation in CSF HVA.
HIAA. MAOA-LPR genotype had a similar but nonsignificant trend on 5-HIAA levels (P = 0.19) with the low activity genotype associated with higher levels of 5-HIAA (Table 1) .
MHPG. CSF MHPG levels did not differ between the two genotype groups (Table 1).
Effect of alcoholism, BMI, height and smoking on CSF monoamine metabolites levels Alcoholism. As previously reported, 22, 42 mean HVA and MHPG values were significantly lower in alcoholics as compared to controls (HVA: t = 3.16; P = 0.0018); (MHPG: t = 5.56; P = 0.0001) (see Table 2 ). In contrast, no differences were reported between alcoholics and controls for 5-HIAA concentrations (t = À0.10; P = 0.91).
Smoking. HVA and MHPG CSF concentrations were inversely correlated with the number of cigarettes smoked/day, while we did not find any significant Association between MAOA, dopamine function and BMI F Ducci et al effect of smoking on 5-HIAA levels (see Table 2 ). Since the effect of smoking on 5-HIAA has been reported in depressed patients, 43 we examined the effect of smoking versus nonsmoking on 5-HIAA levels. Smokers had lower 5-HIAA (67.1, s.e. 2.4) compared to nonsmokers (73.5, s.e. 3.6), a detectable but nonsignificant difference (F = 2.17, P = 0.14).
BMI and height. CSF levels of all three metabolites tended to be positively correlated with BMI (see Table  2 ). Height was significantly correlated only with 5-HIAA concentrations, in that 5-HIAA levels tended to decrease as height increased. Mean BMI was similar in alcoholics (mean7s.d.: 24.6573.68) and nonalcoholics (mean7s.d.: 24.6673.51). Although smoking is known to influence body weight, in our data set, the mean number of cigarettes smoked per day was not significantly correlated with BMI (b = À0.1770.27; t = À0.65; P = 0.52).
MAOA-LPR genotype and covariate effects on CSF HVA concentrations
The effect of MAOA-LPR genotype on CSF HVA concentrations remained significant after adjusting for alcoholism, BMI, height and smoking (P = 0.011). Mean HVA levels adjusted for all covariates in subjects with high versus low activity genotypes are shown in Figure 1 for the whole sample as well as separately for alcoholics and controls. Table 3 ). Finally, NS did not differ between participants with the high activity genotype (mean NS7s.e. = 17.8470.30) as compared to those with low-activity genotype (mean NS7s.e. = 17.3270.37; df = 2, t = 1.07, P = 0.28).
Effect of MAOA on BMI MAOA-LPR genotypes were significantly associated with variation in BMI (P = 0.005) (see Table 4 ). Participants with the high-activity genotype had a lower BMI. On closer inspection, the effect of MAOA-LPR genotype on BMI was driven primarily by differences in body weight, since average height was similar across genotype groups. The association between MAOA and BMI persisted after accounting for the effect of age on BMI.
Excluding subjects carrying the 5 repeat allele did not change the above-described results.
Discussion
Two major findings emerged from our analyses: lowactivity MAOA-LPR genotype predicted higher CSF HVA concentrations (P = 0.011) and higher BMI (P = 0.005), whereas we found no association between MAOA-LPR genotypes and alcoholism, or the overlapping psychiatric disorders and phenotypes ASPD, IED, BPD, suicide, and NS.
Although the effect of MAOA-LPR on CSF HVA was significant, it was quantitatively small overall, explaining only 3% of interindividual variation in this sample. This implies that the extent to which MAOA-LPR activity determines or influences complex phenotypes, MAOA-LPR genotypes contribute only modestly to the variance in disease risk, particularly when considered in the absence of mitigating environmental interactions, as well as other genes. The effect of MAOA-LPR genotypes on HVA in controls parallels that observed in alcoholics (Figure 1) , indicating a lack of genotype by diagnosis interaction. The Figure 1 Effect of MAOA genotype on HVA levels pmol/ml in alcoholics (N = 120), controls (N = 46) and in the whole sample. Mean HVA levels are adjusted for smoking, height and BMI in all the three groups and for diagnosis of alcoholism in the whole sample (ANCOVA). HA = high activity; LA: low activity; s.e. = standard error. Association between MAOA, dopamine function and BMI F Ducci et al association between genotype and HVA persists even after accounting for potential confounds including alcoholism, smoking behavior, BMI and height. A similar, although nonsignificant, trend was found for CSF 5-HIAA, and MAOA-LPR seemed to have no effect on MHPG. The similar effect of genotype on HVA and 5-HIAA is not surprising since the concentrations of these two metabolites are highly correlated (r = 0.63, P < 0.0001). However, the genotype effects we observed on CSF HVA and, to a lesser extent, on 5-HIAA, were in a direction opposite to expectations based on in vitro studies of allele-associated enzyme expression; 12, 14 although MAOA inhibitors are known to decrease monoamine metabolite levels, 1, 44 in our sample it was the genotype conferring high, rather than low, MAOA activity that was associated with lower HVA levels.
One obvious explanation for the correlation of low MAOA activity genotypes to high CSF HVA is that it is simply a chance finding. We tested for correlations between MAOA-LPR and HVA, MHPG and 5-HIAA, resulting in three independent tests, thus increasing the risk of a type 1 error. A common solution is to apply Bonferroni's correction for multiple testing. In our case, the association between MAOA genotype and HVA that we detected in the whole sample maintained its significance. Alternatively, the relationship may be authentic. At least two other studies have investigated the relationship between MAOA-LPR and CSF HVA. Both studies found significant effects. Consistent with our findings, Jonsson et al. 30 found that genotypes conferring low levels of MAOA activity tended to be associated with higher HVA among males. However, Zahlsman et al. 31 found that high-activity genotypes were associated with higher HVA. Including our results presented here, an effect of MAOA-LPR on HVA appears to be a consistent finding across three independent studies, but the direction of the association is inconsistent. CSF HVA concentrations may be altered by the rate of biosynthesis, release, and reuptake of DA as well as by its metabolism via MAOA, MAOB, and catechol-Omethyltransferase (COMT), which methylates DA. Adaptive changes in central monoamine systems may occur such that the simple high MAOA activity/high HVA, HIAAA, MHPG correspondences are not seen or are even reversed, as we and Jonsson et al. observe for HVA among males.
Another possible explanation for the conflicting results is the presence of linkage disequilibrium between MAOA-LPR and another functional locus either in MAOA or in the MAOB gene, or other functional interaction in this gene region. MAOB is in tail-to-tail configuration with MAOA some 60 kb apart. As MAOB is also expressed in human brain 45 and metabolizes DA, 2, 46 it may also be modulating turnover of DA and other monoamine neurotransmitters in the human. MAOB appears to metabolize DA 2 but in fact it is primarily located in serotonin neurons. 47 MAOA and MAOB are not in the same block of conserved linkage disequilibrium. 48 However, a locus affecting transcription of one gene might affect the other, although this possibility is speculative. Although a functional effect of MAOA-LPR has been demonstrated in cell lines 12, 14 and human fibroblasts, 13 its effect on MAOA mRNA and MAOA protein levels in human post-mortem brain tissue appears to be very weak and insignificant. 49 In the Balciuniene et al. 40 study, a haplotype composed of the low activity MAOA-LPR 3 repeat allele and a SNP from an intronic region in MAOB was significantly associated with decreased MAOA function, whereas other MAOA-LPR/MAOB SNP haplotypes containing the MAOA-LPR 3 repeat allele were associated with higher expression.
Unrecognized functional complexity in the MAO region may also help explain the increasing number of contradictory studies on MAOA's effect on externalizing behaviors. Indeed, it is unclear whether the low or high MAOA-LPR allele is the risk allele for vulnerability to externalizing behaviors. The majority of reports find an increase in the frequency of low activity alleles in patients with externalizing disorders. 5, 6, 18 However, there are some important exceptions. For example, increased aggression 17 and vulnerability to ADHD 16 were both associated with alleles conferring high MAOA activity. Without controlling for child adversity and for the interaction between genotype and child adversity, Foley et al. 18 found that high, rather than low, activity alleles were associated with increased risk of developing CD.
Our second major finding was an association between BMI and MAOA-LPR (P = 0.005). The effect size of MAOA-LPR genotype on BMI was not strong: only 4% of the total variance in BMI. However, BMI is a complex trait that is the product of many different factors, and BMI is itself an important predictor of other common, complex traits such as adult onset diabetes. Therefore, it is unlikely that a locus such as MAOA would explain more of the variance in BMI than a small percent, and if replicated, this finding could be rather important from a public health perspective. The low-activity genotype was associated with higher BMI, and the effect persisted after accounting for age. Other evidence for a role for MAOA in modulating BMI exists, and the effects that have been observed are directionally consistent. For example, one of the principal side effects of MAOA inhibitors is weight gain. 39 In a recent linkage study on anorexia nervosa, high-activity alleles were found to be mildly overtransmitted in patients with low BMI, 50 while in another study low MAOA enzyme activity was associated with severe obesity (BMIX35 kg/m 2 ). 38 To our knowledge, our study is the first to report an effect of the MAOA-LPR locus on BMI in a population of mainly nonobese individuals. Although this association is intriguing, it is preliminary and in need of further investigation before any firm conclusions should be drawn.
We hypothesized that monoamine metabolite levels would more directly reflect the action of MAOA Association between MAOA, dopamine function and BMI F Ducci et al genotype than complex behaviors to which this locus has been linked. CSF HVA and HIAA levels have been linked to complex behaviors in studies conducted on samples that partially overlap with the present study, and the findings include association of low CSF HVA to alcoholism. 42, 51 However, we found no evidence that MAOA-LPR alone was associated with alcoholism or other externalizing phenotypes. There are two possible explanations for these negative results. First, MAOA-LPR does not predispose to alcoholism in this population, and the contribution of MAOA-LPR to CSF HVA does not have any impact on the risk of alcoholism. Second, our data set may have been underpowered for eliciting a statistically significant MAOA-LPR genotype effect on alcoholism, a more multifactorial entity. The effect of MAOA-LPR on more complex and genetically heterogeneous phenotypes is likely to be subtle, and the ability to detect its influence will be dependent upon numerous factors, including sample size but also availability of data on interacting genes and environmental factors.
Other than the unavailability of a replication data set, there were several other limitations to our study. The same trend for MAOA genotype to predict CSF HVA in alcoholics was seen in controls, but we had CSF HVA in a relatively small number of controls. Second, we did not have available data on environmental variables, such as maltreatment, that have been shown to increase vulnerability to externalizing behaviors and to interact with MAOA-LPR genotype. Third, the population from which our samples derive does not represent a random population (in fact, the patients are fairly extreme type II alcoholics), and therefore results may not generalize.
In summary, our findings, which were based on a larger CSF monoamine data set than has previously been studied, generally support prior conclusions indicating that genetic variation in MAOA modulates DA turnover in human CNS. However, the effect we detected, while consistent with Jonsson's results among males, 30 was in the opposite direction than expected from in vitro studies of effects of MAOA-LPR on expression and the previous report from Zalsman et al. 31 Adaptive changes in central monoamine function as well as additional functional complexity in the MAO gene region, including other polymorphisms and interaction between the two MAO genes, might partially or completely explain discrepancies between studies, particularly the finding by Josson et al. and us that higher CSF HVA levels are found in males with the highest MAOA activity. Overall, the effect sizes are not large and CSF HVA level itself is not simply a direct consequence of enzyme activity. Finally, our work suggests that MAOA might be involved in the regulation of body weight measured as BMI. Further independent samples are necessary to confirm this preliminary finding.
